StockData
Lumexa Imaging Holdings, Inc. logo

Lumexa Imaging Holdings, Inc. (LMRI) stock

LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.26+0.20 (+1.42%)

Close on Nov 20, 2026Market cap $1.37BP/E –Yield –

Lumexa Imaging free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$20.60M–
Q2 FY2026Jun 30, 2026$23.13M–
Q1 FY2026Mar 31, 2026-$2.38M–
Q3 FY2025Sep 30, 2025-$1.77M–
Q2 FY2025Jun 30, 2025-$2.53M–
Q1 FY2025Mar 31, 2025-$14.96M–

More Lumexa Imaging figures

See a number that looks wrong?